Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias

Abstract

The need for cost-efficient diagnostic and prognostic markers of AD is urgent. Plasma and digital cognitive markers provide complementary diagnostic contributions. Combination of these markers holds promise for scalable diagnosis and prognosis. Future validation in community cohorts is needed to inform clinical implementation.